---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-110612"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2022-10-21T23:59:59+00:00"
generated_at: "2026-06-23T02:00:26.058053+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Abbott extends change-in-control agreements with named executive officers through Dec 2024

## Summary
- Extension moves expiration date from Dec 31, 2022 to Dec 31, 2024 for named executive officers.
- Agreements provide severance and other benefits upon a change in control of the company.
- Previously reported Agreements with executive officers extended by two years effective Oct 18, 2022.

## SEC filing metadata
- accession: 0001104659-22-110612
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2022-10-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465922110612/0001104659-22-110612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465922110612/tm2228558d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-110612
- JSON: https://secwatch.observer/filing/0001104659-22-110612.json
- Plain text: https://secwatch.observer/filing/0001104659-22-110612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.